Lauren Schoeffler is an associate in the firm’s Business Law Department and a member of its Technology Companies & Life Sciences group. She represents early- and late-stage companies in the life sciences industry throughout their corporate life cycle, including start-up, equity financings, strategic transactions, and ongoing corporate matters, such as SEC compliance and corporate governance. She also represents venture capital and private equity funds focused on life sciences companies.
Ms. Schoeffler joined Goodwin in 2017. Prior to joining Goodwin, she was an associate in the Boston office of Nixon Peabody LLP.
While attending law school, Ms. Schoeffler was the Executive Editor of the American Journal of Law and Medicine.
Boston University School of Law